SAMIR HADDAD: Open Payments
NPI 1568673135 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,505 in 21 payments from 9 companies in 2025. Trend: 2023 $851 · 2024 $872 · 2025 $1,505
Food & beverage: $1,505
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $270 |
| Corcept Therapeutics | 2 | $268 |
| AstraZeneca Pharmaceuticals LP | 2 | $250 |
| Braeburn Inc. | 8 | $232 |
| Amgen Inc. | 2 | $225 |
| Penumbra, Inc. | 1 | $126 |
| Bard Peripheral Vascular, Inc. | 1 | $77 |
| Lilly USA, LLC | 2 | $37 |
| Dexcom, Inc. | 1 | $20 |
Products named: REZDIFFRA, Korlym, BRIXADI, Indigo System, BREZTRI, AIRSUPRA, REPATHA, EVENITY.
Industry payments across NJ — which companies pay providers there.
